Significantly reduce carbon impact

Manufacturing medicinal and pharmaceutical products can be particularly energy intensive. Processing, cleanrooms, lighting, heating and ventilation all add to a plant’s carbon footprint as well as having a significant financial impact.  

Due to the critical nature of producing large batches of life saving medicines and products, pharma companies typically have back-up energy assets in place, to ensure secure and reliable power for manufacturing. Some of these assets – standby generators, batteries and Uninterruptible Power Supplies (UPS), are ideal sources to provide Security of Supply for the national power system when it’s needed, via Demand Response services. 

In doing so, pharma companies become energy providers to the grid and enable more renewable electricity to be consumed, all while benefitting from a new revenue stream for the business. This additional revenue source has the added benefit of helping depreciating assets to pay for themselves.